Lv51
880 积分 2024-07-09 加入
From development to clinical success: the journey of established and next-generation BTK inhibitors
3天前
已完结
Resistance mechanisms and approach to chronic lymphocytic leukemia after BTK inhibitor therapy
3天前
已完结
Small-molecule BTK inhibitors: From discovery to clinical application
3天前
已完结
Recent research of BTK inhibitors: Methods of structural design, pharmacological activities, manmade derivatives and structure–activity relationship
3天前
已完结
PROTAC targeted protein degraders: the past is prologue
8天前
已完结
Developing Pharmacokinetic/Pharmacodynamic Relationships With PROTACs
8天前
已完结
Abstract LB163: Discovery and characterization of QTX3544, a potent, selective, and orally bioavailable allosteric G12V preferring multi KRAS inhibitor
1个月前
已关闭
Enhancing SN38 prodrug delivery using a self-immolative linker and endogenous albumin transport
1个月前
已完结
Glecirasib in KRASG12C-mutated nonsmall-cell lung cancer: a phase 2b trial
1个月前
已完结
Molecular Evolution of Multivalent OncoFAP Derivatives with Enhanced Tumor Uptake and Prolonged Tumor Retention
1个月前
已完结
皖公网安备34019202002308
